of medical systems 28,529 13,118 13,829 4,562 53,324 7,272 Sale of fashion merchandise and other 74,641 83,588 32,947 45,580 185,082 19,027 514,850 462,079 231,160 240,995 1,011,298 131,239 Expenses and losses Commercial centers 91,303 74,380 49,200 35,399 159,626 23,274 Investment property expenses 58,063 51,326 23,742 25,008 112,262 14,801 Expenses relating to realization of investment property, net of gain from fair value adjustment 103,696 - 103,696 - - 26,433 Hotels operations and management 108,150 117,732 48,722 64,402 240,784 27,568 Cost and expenses of medical systems operation 31,449 36,398 16,167 18,667 101,498 8,016 Cost of fashion merchandise and other 83,291 97,583 32,626 52,413 211,743 21,231 Research and development expenses 22,816 32,377 10,576 15,936 62,851 5,816 General and administrative expenses 24,641 32,310 11,075 17,635 61,857 6,281 Share in losses of associates, net 4,582 3,877 1,743 1,860 7,568 1,168 Financial expenses (income), net 225,139 9,501 74,397 (26,037) (86,560) 57,390 Write down, charges and other expenses (income), net 23,197 36,583 (2,673) 22,579 309,885 5,913 776,327 492,067 369,271 227,862 1,181,514 197,891 Profit (loss) before income taxes (261,477) (29,988) (138,111) 13,133 (170,216) (66,652) Income tax expenses (tax benefit) (5,662) (2,201) (5,760) (498) 86,550 (1,443) Profit (loss) from continuing operations (255,815) (27,787) (132,351) 13,631 (256,766) (65,209) Profit from discontinued operation, net - - - - 9,737 - Profit (loss) for the period (255,815) (27,787) (132,351) 13,631 (247,029) (65,209) Attributable to: Equity holders of the Company (228,940) (93,507) (141,227) (30,212) (264,919) (58,359) Non-controlling interest (26,875) 65,720 8,876 43,843 17,890 (6,850) (255,815) (27,787) (132,351) 13,631 (247,029) (65,209)
ELBIT IMAGING LTD.
CONSOLIDATED COMPREHENSIVE INCOME STATEMENTS
Six months Three months Year Six months ended ended ended ended December June 30 J
'/>"/>
SOURCE Elbit Imaging Ltd. Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 Related medicine technology :1.
Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center2.
ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System3.
U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC4.
Boston Scientific and Philips Healthcare Announce Collaboration to Enhance Imaging Equipment Offering5.
Real Time Medical to Feature Diagnostic Imaging Software @ Innovation Showcase at e-Health 20126.
ClearCanvas Partners With DPR to Offer CaseReader™, an Integrated Technology Structured Reporting Solution for Medical Imaging Professionals7.
Philips demonstrates innovations in nuclear medicine imaging with a comprehensive portfolio of NM applications for IntelliSpace Portal8.
Global Market for Medical Imaging Equipment to Reach $25.3 Billion as Retiring Boomers and Emerging Markets Demand Better Healthcare9.
IMD Adds Substantial Imaging Contracts10.
ICON Medical Imaging Selects AG Mednet to Give Clinical Trial Sponsors Zero-Delay Efficiency and Faster Decision-Making Results11.
Derry Medical and Derry Imaging Select Calypso for Website Redesign